3′H-Cyclopropa[6,7]pregna-4,6-diene-21-carboxylic acid, 6,7-dihydro-17-hydroxy-3-oxo-, (6α,7α,17α)-
-
![3′H-Cyclopropa[6,7]pregna-4,6-diene-21-carboxylic acid, 6,7-dihydro-17-hydroxy-3-oxo-, (6α,7α,17α)- structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/fd1bdb2569874315afb286516a8b7500.png "3′H-Cyclopropa[6,7]pregna-4,6-diene-21-carboxylic acid, 6,7-dihydro-17-hydroxy-3-oxo-, (6α,7α,17α)-")
3′H-Cyclopropa[6,7]pregna-4,6-diene-21-carboxylic acid, 6,7-dihydro-17-hydroxy-3-oxo-, (6α,7α,17α)-
structure -
-
CAS No:
49848-01-3
-
Formula:
C23H32O4
-
Chemical Name:
3′H-Cyclopropa[6,7]pregna-4,6-diene-21-carboxylic acid, 6,7-dihydro-17-hydroxy-3-oxo-, (6α,7α,17α)-
-
Synonyms:
3′H-Cyclopropa[6,7]pregna-4,6-diene-21-carboxylic acid,6,7-dihydro-17-hydroxy-3-oxo-,(6α,7α,17α)-;6α,7α-Dihydro-17-hydroxy-3-oxo-3′H-cyclopropa[6,7]-17α-pregna-4,6-diene-21-carboxylic acid;96626-94-7
-
CAS No:
Description
Prorenoate is a steroidal aldosterone antagonist with potassium-sparing diuretic activity. Prorenoate antagonizes the activity of aldosterone at the mineralocorticoid receptor in the nephron and thereby prevents sodium reabsorption. This interferes with the sodium/potassium exchanger and causes sodium and water excretion while reducing potassium excretion.
3′H-Cyclopropa[6,7]pregna-4,6-diene-21-carboxylic acid, 6,7-dihydro-17-hydroxy-3-oxo-, (6α,7α,17α)- Basic Attributes
372.5 g/mol
372.50
WET36J3301
C84117
Drug Information
potassium 3-(17 beta-hydroxy-6 beta,7 beta-methylene-3-oxo- 4-androstene-17 alpha-yl)propionate
Computed Properties
Molecular Weight:372.5
XLogP3:2.7
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:3
Exact Mass:372.23005950
Monoisotopic Mass:372.23005950
Topological Polar Surface Area:74.6
Heavy Atom Count:27
Complexity:741
Defined Atom Stereocenter Count:8
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation